{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:35:34Z","timestamp":1782747334038,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008967","name":"Bilim Akademisi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114787","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T12:17:50Z","timestamp":1663849070000},"page":"114787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels"],"prefix":"10.1016","volume":"244","author":[{"given":"Dilara","family":"Akman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Denzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan W.","family":"Nafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Wolber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-9509","authenticated-orcid":false,"given":"Miyase G\u00f6zde","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114787_bib1","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2022.114787_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2022.114787_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114787_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2022.114787_bib5","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/jhet.2837","article-title":"Cardiovascular calcium channel blockers: historical overview, development and new approaches in design","volume":"54","author":"Drapak","year":"2017","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/jm020354w","article-title":"Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines","volume":"46","author":"Zamponi","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(24)12129-3","article-title":"Synthesis and evaluation of a new class of nifedipine analogs with T-type calcium channel blocking activity","volume":"61","author":"Phani Kumar","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114787_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.129898","article-title":"Crystal structure determination and computational studies of 1,4-dihydropyridine derivatives as selective T-type calcium channel blockers","volume":"1230","author":"G\u00fcnd\u00fcz","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2022.114787_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/19336950.2020.1740487","article-title":"T-type channels in neuropathic pain - villain or victim?","volume":"14","author":"Weiss","year":"2020","journal-title":"Channels"},{"key":"10.1016\/j.ejmech.2022.114787_bib10","first-page":"1","article-title":"Central and peripheral contributions of T-type calcium channels in pain","author":"Harding","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.ejmech.2022.114787_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.biocel.2019.01.008","article-title":"T-type calcium channels: from molecule to therapeutic opportunities","volume":"108","author":"Weiss","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114787_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1021\/acschemneuro.9b00031","article-title":"T-type channel druggability at a crossroads","volume":"10","author":"Weiss","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114787_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2019.04.043","article-title":"Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel","volume":"177","author":"Zhao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114787_bib14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","article-title":"Cryo-EM structures of apo and antagonist-bound human Cav3.1","volume":"576","author":"Zhao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114787_bib15","doi-asserted-by":"crossref","DOI":"10.15406\/japlr.2017.05.00148","article-title":"Dihydropyridines as calcium channel blockers: an overview","volume":"5","author":"Bandyopadhyay","year":"2017","journal-title":"J. Anal. Pharm. Res."},{"key":"10.1016\/j.ejmech.2022.114787_bib16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00424-013-1376-z","article-title":"Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity","volume":"466","author":"Bladen","year":"2014","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2022.114787_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00424-014-1566-3","article-title":"1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain","volume":"467","author":"Bladen","year":"2015","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2022.114787_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.05.032","article-title":"Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-\/T-type calcium channel blocking activity","volume":"155","author":"Schaller","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103187","article-title":"Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-\/T-type calcium channels","volume":"91","author":"Ayg\u00fcn Cevher","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib20","first-page":"8","article-title":"Anatomical therapeutic chemical classification system","author":"Nahler","year":"2009","journal-title":"Dict. Pharm. Med."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114787_bib21","first-page":"85","article-title":"1,4-Dihydropyridine antihypertensive drugs: recent advances in photostabilization strategies","volume":"11","author":"De Luca","year":"2019","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2022.114787_bib22","first-page":"527","article-title":"Use of pluronic surfactants in gel formulations of photosensitive 1,4-dihydropyridine derivatives: a potential approach in the treatment of neuropathic pain","volume":"13","author":"Ioele","year":"2021","journal-title":"Pharm. Times"},{"key":"10.1016\/j.ejmech.2022.114787_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010028","article-title":"A new generation of dihydropyridine calcium channel blockers: photostabilization of liquid formulations using nonionic surfactants","volume":"11","author":"Ioele","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2022.114787_bib24","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1016\/j.tet.2008.01.104","article-title":"Photochemistry of Hantzsch 1,4-dihydropyridines and pyridines","volume":"64","author":"Fasani","year":"2008","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114787_bib25","series-title":"Ultrason. Sonochem.","first-page":"265","article-title":"Ultrasound effect on the aromatic nucleophilic substitution reactions on some haloarenes","author":"Me\u010diarov\u00e1","year":"2003"},{"key":"10.1016\/j.ejmech.2022.114787_bib26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/jo991699y","article-title":"Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides, and triflates","volume":"65","author":"Wolfe","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib27","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1016\/S0040-4020(99)00318-X","article-title":"Convenient amination of weakly activated thiophenes, furans and selenophenes in aqueous media","volume":"55","author":"Prim","year":"1999","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114787_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1246\/bcsj.64.42","article-title":"Aromatic nucleophilic substitution of halobenzenes with amines under high pressure","volume":"64","author":"Ibata","year":"1991","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ejmech.2022.114787_bib29","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0b013e3283388045","article-title":"Benidipine, a dihydropyridine L-type\/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejmech.2022.114787_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1527-3466.2002.tb00084.x","article-title":"Efonidipine hydrochloride: a dual blocker of L- and T-type Ca2+ channels","volume":"20","author":"Tanaka","year":"2002","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejmech.2022.114787_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/catal10091019","article-title":"Recent approaches to chiral 1,4-dihydropyridines and their fused analogues","volume":"10","author":"Rucins","year":"2020","journal-title":"Catalyst"},{"key":"10.1016\/j.ejmech.2022.114787_bib32","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00424-015-1725-1","article-title":"Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels","volume":"467","author":"Gadotti","year":"2015","journal-title":"Pflugers Arch. Eur. J. Physiol."},{"key":"10.1016\/j.ejmech.2022.114787_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2022.114787_bib34","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1002\/j.1460-2075.1996.tb00592.x","article-title":"The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines","volume":"15","author":"Schuster","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2022.114787_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0165-6147(98)01171-7","article-title":"Structural basis of drug binding to L Ca2+ channels","volume":"19","author":"Striessnig","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114787_bib36","doi-asserted-by":"crossref","first-page":"41504","DOI":"10.1074\/jbc.M007165200","article-title":"Serine residue in the IIIS5-S6 linker of the L-type Ca2+ channel alpha 1C subunit is the critical determinant of the action of dihydropyridine Ca2+ channel agonists","volume":"275","author":"Yamaguchi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib37","first-page":"117","article-title":"Structural basis for inhibition of a voltage-gated Ca 2+ channel by Ca 2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.ejmech.2022.114787_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114787_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114787_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10822-006-9078-7","article-title":"Efficient overlay of small organic molecules using 3D pharmacophores","volume":"20","author":"Wolber","year":"2006","journal-title":"J. Comput. Mol."},{"key":"10.1016\/j.ejmech.2022.114787_bib41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wcms.1468","article-title":"Next generation 3D pharmacophore modeling","volume":"10","author":"Schaller","year":"2020","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114787_bib43","doi-asserted-by":"crossref","unstructured":"W.A. Catterall, M.J. Lenaeus, T.M. Gamal El-Din, Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels, Https:\/\/Doi.Org\/10.1146\/Annurev-Pharmtox-010818-021757. 60 (2020) 133\u2013154. doi:10.1146\/ANNUREV-PHARMTOX-010818-021757.","DOI":"10.1146\/annurev-pharmtox-010818-021757"},{"key":"10.1016\/j.ejmech.2022.114787_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2298\/JSC151206035G","article-title":"Synthesis, structural characterization and myorelaxant activity of 4-naphthylhexahydroquinoline derivatives containing different ester groups","volume":"81","author":"G\u00fcnd\u00fcz","year":"2016","journal-title":"J. Serb. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114787_bib45","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.bmc.2017.02.015","article-title":"Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain","volume":"25","author":"Teleb","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114787_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/chir.23419","article-title":"Liquid chromatography enantiomeric separation of chiral ethanolamine substituted compounds","volume":"34","author":"Firooz","year":"2022","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2022.114787_bib47","series-title":"Handb. Vib. Spectrosc.","first-page":"731","article-title":"Vibrational circular dichroism","author":"Na\ufb01e","year":"2002"},{"key":"10.1016\/j.ejmech.2022.114787_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114233","article-title":"Chiral resolution and absolute configuration determination of new metal-based photodynamic therapy antitumor agents","volume":"204","author":"Armstrong","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2022.114787_bib49","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1520-636X(2000)12:4<172::AID-CHIR3>3.0.CO;2-6","article-title":"Determination of the structure of chiral molecules using ab initio vibrational circular dichroism spectroscopy","volume":"12","author":"Stephens","year":"2000","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2022.114787_bib50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/chir.10287","article-title":"Absolute configuration determination of chiral molecules in the solution state using vibrational circular dichroism","volume":"15","author":"Freedman","year":"2003","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2022.114787_bib51","first-page":"14","article-title":"Vibrational circular dichroism: absolute con\ufb01guration determination in solution","volume":"19","author":"Kellenbach","year":"2007","journal-title":"Spectrosc. Eur."},{"key":"10.1016\/j.ejmech.2022.114787_bib52","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","author":"Bateman","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.114787_bib53","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/prot.22234","article-title":"Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures","volume":"75","author":"Labute","year":"2009","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.ejmech.2022.114787_bib54","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114787_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0022-2836(81)90087-5","article-title":"Identification of common molecular subsequences","volume":"147","author":"Smith","year":"1981","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114787_bib56","series-title":"Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters","first-page":"43","author":"Bowers","year":"2007"},{"key":"10.1016\/j.ejmech.2022.114787_bib57","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9-Hoover chains: the canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2022.114787_bib58","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"issue":"33\u20138","key":"10.1016\/j.ejmech.2022.114787_bib59","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.ejmech.2022.114787_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-13366-4","article-title":"Arginase structure and inhibition: catalytic site plasticity reveals new modulation possibilities","volume":"7","author":"Mortier","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:43:58Z","timestamp":1759329838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422006894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":60,"alternative-id":["S0223523422006894"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114787","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114787"}}